
1. General Information
Rebopag 25 mg Tablet contains Eltrombopag 25 mg. It belongs to a class of medicines called thrombopoietin receptor agonists. Eltrombopag helps stimulate the bone marrow to produce more platelets and is prescribed for certain conditions associated with low platelet counts.
Rebopag is a prescription medicine and should be taken only under the supervision of a qualified healthcare professional.
2. Product Information
- Brand: Rebopag 25 mg Tablet
- Active ingredient: Eltrombopag 25 mg
- Dosage form: Oral tablet
- Therapeutic class: Platelet-stimulating agent / thrombopoietin receptor agonist
- Route: Oral
- Prescription: Required
- Manufacturer/Marketer: MSN Laboratories Pvt. Ltd. is listed for Rebopag 25 mg in Indian medicine listings.
- Storage: Store according to the product label; an Indian listing specifies storage below 30°C.
3. Uses of Rebopag 25 mg
Rebopag 25 mg may be prescribed for conditions involving low platelet counts, including:
- Chronic immune thrombocytopenia (ITP) when previous treatments have not provided adequate response.
- Severe aplastic anemia (SAA) in appropriate patients.
- Hepatitis C-associated thrombocytopenia in specific treatment settings.
The exact indication varies by country and product labeling.
4. Benefits of Rebopag 25 mg
The principal therapeutic benefit of eltrombopag is helping increase platelet production.
Potential benefits include:
- Helps raise platelet counts in eligible patients.
- May reduce the risk of bleeding associated with very low platelet counts.
- Can provide a treatment option for patients with chronic ITP who have not responded adequately to other treatments.
- May support platelet production in selected patients with severe aplastic anemia.
The objective is generally to achieve an appropriate platelet count rather than unnecessarily normalising the platelet count.
5. Side Effects of Rebopag 25 mg
Like other prescription medicines, eltrombopag can cause side effects. Important potential adverse effects include:
- Liver-function abnormalities or liver injury
- Increased risk of blood clots
- Nausea
- Diarrhea
- Headache
- Fatigue
- Cough
- Fever
- Anemia
Eltrombopag carries important warnings concerning hepatotoxicity and thrombotic/thromboembolic complications, so medical monitoring is important.
6. Common Side Effects
Depending on the indication and individual patient, commonly reported adverse reactions can include:
- Nausea
- Diarrhea
- Headache
- Fatigue
- Cough
- Fever
- Anemia
- Increased liver enzymes
Not every patient experiences these effects, and the frequency can differ according to the condition being treated.
7. How to Use Rebopag 25 mg
Rebopag should be taken exactly as prescribed by the doctor.
The appropriate dose depends on factors such as the patient's condition, platelet count, age, liver function, other medicines, and treatment response. Eltrombopag dosing is individualised, and the lowest dose needed to achieve the desired platelet response is generally used.
Important administration considerations include:
- Take the tablet according to the prescribed schedule.
- Do not change the dose without medical advice.
- Do not stop treatment suddenly unless instructed by your doctor.
- Follow the product instructions regarding food and mineral-containing products because certain minerals can interfere with eltrombopag absorption.
- Regular platelet and liver-function monitoring may be required.
8. How Rebopag 25 mg Works
Rebopag contains eltrombopag, which acts as a thrombopoietin receptor agonist.
It stimulates thrombopoietin receptors involved in the production of blood platelets. This encourages bone-marrow cells involved in platelet formation to produce more platelets, thereby helping increase the platelet count.
9. Safety Advice
Rebopag should be used under medical supervision.
Important safety considerations:
- Have platelet counts monitored as recommended by your doctor.
- Liver-function tests may be necessary during treatment.
- Tell your doctor if you have liver disease or a history of blood clots.
- Seek urgent medical attention for symptoms that could indicate a blood clot, such as sudden chest pain, difficulty breathing, severe abdominal pain, or swelling/pain in a limb.
- Do not exceed the prescribed dose.
- Inform your doctor about all prescription medicines, OTC medicines, vitamins, and supplements you take.
- Discuss pregnancy or breastfeeding with your healthcare professional before treatment.
- Keep the medicine out of reach of children.
- Do not use a damaged, expired, or improperly stored product.
Eltrombopag can increase the risk of thrombotic complications and can cause liver-related problems, making appropriate monitoring particularly important.
10. Frequently Asked Questions (FAQs)
Q1. What is Rebopag 25 mg used for?
Rebopag 25 mg is used to treat certain conditions associated with low platelet counts, including chronic immune thrombocytopenia and severe aplastic anemia. It has also been used for thrombocytopenia associated with chronic hepatitis C in specific treatment settings.
Q2. What is the active ingredient in Rebopag 25 mg?
The active ingredient is Eltrombopag 25 mg.
Q3. Is Rebopag 25 mg a prescription medicine?
Yes. It should be used under the supervision of a qualified healthcare professional.
Q4. How does Rebopag increase platelets?
Eltrombopag stimulates the thrombopoietin receptor pathway, encouraging platelet production in the bone marrow.
Q5. Can I stop Rebopag when my platelet count improves?
Do not stop or change treatment without consulting your doctor. Platelet counts can fall after treatment is discontinued, and monitoring may be required.
Q6. Does Rebopag have serious side effects?
It can. Liver toxicity and blood-clot complications are important safety concerns associated with eltrombopag.
Q7. Does everyone taking Rebopag need the same dose?
No. Eltrombopag dosing is individualised according to the indication and platelet response.
Q8. Can Rebopag be taken with other medicines?
Some medicines and mineral-containing products can interact with eltrombopag. Tell your healthcare professional about everything you take before starting treatment.
11. Substitutes for Rebopag 25 mg
Medicines containing eltrombopag 25 mg may be considered alternatives when clinically appropriate. One well-known eltrombopag brand is Revolade, while other generic or branded eltrombopag products may be available in different countries.
A substitute should not be selected solely by brand or price. The doctor or pharmacist should confirm the active ingredient, strength, formulation, indication, and suitability for the patient.
12. SEO Keywords
Product Keywords
- Rebopag 25 mg Tablet
- Rebopag 25 mg
- Rebopag 25 mg Eltrombopag
- Eltrombopag 25 mg Tablet
- Eltrombopag tablets supplier
- Eltrombopag 25 mg manufacturer
- Eltrombopag 25 mg exporter
- Eltrombopag medicine supplier India
- Eltrombopag pharmaceutical exporter
- Eltrombopag tablets wholesale supplier
B2B / Export Keywords
- Rebopag 25 mg Tablet exporter from India
- Rebopag 25 mg supplier from India
- Rebopag 25 mg pharmaceutical exporter
- Rebopag 25 mg wholesale supplier India
- Eltrombopag 25 mg exporter from Nagpur India
- Eltrombopag 25 mg medicine supplier India
- Eltrombopag 25 mg international pharmaceutical supplier
- Eltrombopag 25 mg B2B medicine supplier
- Indian pharmaceutical exporter for Eltrombopag
- prescription medicine exporter from India
Country-Targeted SEO Keywords
- Rebopag 25 mg exporter to USA
- Rebopag 25 mg supplier to UK
- Rebopag 25 mg exporter to Australia
- Rebopag 25 mg supplier to Singapore
- Rebopag 25 mg exporter to Canada
- Rebopag 25 mg supplier to South Korea
- Rebopag 25 mg exporter to UAE
- Eltrombopag 25 mg exporter from India to USA
- Eltrombopag 25 mg exporter from India to UK
- Eltrombopag 25 mg supplier from India to Australia
- Eltrombopag 25 mg supplier from India to Canada
- Eltrombopag 25 mg pharmaceutical supplier to UAE
- Eltrombopag 25 mg medicine exporter from Nagpur India
Keywords







